Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The effects of the diphosphonates etidronate and clodronate were studied in 144 patients with Paget's disease. All five programmes of treatment tested induced a similar suppression of disease activity as judged by serum alkaline phosphatase concentrations, but the proportion of patients responding and the duration of responses differed significantly between programmes. The proportion responding to etidronate 5-10 mg/kg/day for six months was less than for other regimens, and the most sustained response was after treatment with clodronate 1600 mg daily for six months. More complete biochemical suppression was associated with the more prolonged responses irrespective of the regimen used.

Type

Journal article

Journal

The Quarterly journal of medicine

Publication Date

09/1987

Volume

64

Pages

755 - 767

Addresses

Department of Human Metabolism and Clinical Biochemistry, University of Sheffield Medical School.

Keywords

Humans, Osteitis Deformans, Diphosphonates, Clodronic Acid, Etidronic Acid, Alkaline Phosphatase, Administration, Oral, Drug Administration Schedule, Dose-Response Relationship, Drug